... health care professionals not to use that batch while health authorities and GlaxoSmithKline investigate," she said. White said the batch at issue, ... to stop using them was given. White said U.K.-based GlaxoSmithKline wrote to Canadian health care professionals advising ... million doses of the vaccine have been distributed in Canada. GlaxoSmithKline is the world's second largest drug maker ...

... to receive double-digit royalties from sales if the product is commercialized. GlaxoSmithKline will have an option to exclusively in-license NicVAX on a worldwide basis and a license ... the end of 2010. While Nabi will be responsible for the development of this vaccine, GlaxoSmithKline on exercising its option will take responsibility for further development and commercialization of NicVAX. Company ...

... declined to say how many doses had been administered before the advice to stop using them was given. White says GlaxoSmithKline wrote to Canadian healthcare professionals advising them to stop using the ... a total of 7.5 million doses of the vaccine have been distributed in Canada. GlaxoSmithKline Recalls H1N1 Vaccine in Canada Over 'Life-Threatening' Allergy Risk ...

... lab equipment USA Today LONDON (AP) — British drug maker GlaxoSmithKline PLC will provide anti-doping laboratory equipment to the 2012 Olympics after signing on as the London ... GlaxoSmithKline (GSK) gets drug testing deal for London 2012 OlympicsHarlow Herald 24 GlaxoSmithKline named as tier three sponsor for London 2012More Than The Games GSK signs as 2012 ...

... Image: whitman-ma.gov "This petition is to bring criminal charges against GlaxoSmithKline. The medication they made has caused numerous deaths not to mention birth defects. ... birth defects was hidden therefore taking the right to make an informed decision was taken away from Mothers. GlaxoSmithKline needs to be held criminally accountable for their misinformation and blantant lies. It is for ...

... of allergic reactions. The batch of vaccine was apparently sent out in late October, but GlaxoSmithKline only sent out the recall on November 18th. Estimates suggest that the majority of ... raised eyebrows within the pharmaceutical company that distributed the H1N1 vaccines, GlaxoSmithKline. The Canadian government were also said to have published a statement on the vaccine recall, telling people ...

... by Kevin Via: AP: Pharmaceuticals company GlaxoSmithKline PLC said Tuesday it has advised medical staff in Canada to ... health care professionals not to use that batch while health authorities and GlaxoSmithKline investigate," she said. White said the batch at issue, ... to stop using them was given. White said U.K.-based GlaxoSmithKline wrote to Canadian health care professionals advising ...

Melly Alazraki Not two months after the Swiss start-up Cytos's experimental anti-smoking vaccine failed in a mid-stage study, Nabi Biopharmaceuticals (NABI) and GlaxoSmithKline (GSK) have signed a licensing agreement for Nabi's own anti-smoking vaccine, NicVAX. The deal, which could potentially be worth more than half a billion dollars, helped push NABI shares 25% higher. NicVAX is an ...

... CLICKING HERE. Canada’s doctors told to stop using swine flu vaccine BBC GlaxoSmithKline has advised doctors in Canada to stop using a batch of its swine flu vaccine, amid reports of ... . The reports say one in 20,000 people suffered adverse reactions to the batch of GlaxoSmithKline’s Aperanix vaccine. This is five times the expected number. None of the patients reportedly suffered ...

... own conclusion. In related news: early this morning comes disturbing news that Big Pharma giant GlaxoSmithKline has notified Canadian healthcare professionals that a batch of their vaccine may trigger life-threatening allergies. GlaxoSmithKline, Sanofi-Aventis, AstraZeneca, CSL Limited, and Novartis are the major multinationals producing the ...

... called NicVax with the aid of $4.1 million in funding from the National Institutes of Health. Earlier today, the vaccine received a booster shot: Nabi signed a $540 million licensing deal with pharma giant GlaxoSmithKline and is starting Phase III clinical trials. Now that the smoking rate in the U.S. is on the rise again for the first time since 1994, Nabi's timing couldn't be better. ...

ChinaBio Today submits: GlaxoSmithKline (GSK) and Gilead Sciences (GILD) agreed on an Asian marketing plan for their jointly owned treatment for hepatitis B, Viread® (tenofovir disoproxil fumarate). GSK will have exclusive rights to commercialize the drug for hepatitis B in China. Gilead will own exclusive rights Hong Kong, Singapore, South Korea and Taiwan. Each company will pay royalties to ...

GlaxoSmithKline, a pharmaceutical company that manufactures H1N1 vaccination, has requested that Canadian medical centers not use one batch of the immunizations. Spokesperson for GlaxoSmithKine state that this batch has caused six serious allergic reactions; this is greater than expected. The recalled batch contained approximately 172,000 doses (a total of 7.5 million doses have been ...

Could denture cream become GlaxoSmithKline (GSK)'s new Paxil -- a blockbuster product that becomes the target of mass litigation? Lawyers have brought at least a dozen cases and are potentially preparing as many as 3,000 against GSK and Procter & Gamble (PG) over the use of zinc in the denture creams Poligrip and Fixodent, respectively.

... Agreement for donation of pandemic H1N1 vaccine signed GlaxoSmithKline (GSK) is to donate 50 million doses of pandemic ... , Dr Margaret Chan, and the Chief Executive Officer of GlaxoSmithKline, Mr Andrew Witty. “We welcome this very generous donation by GlaxoSmithKline, which will go to protect the health of the world’s poorest people. This is a real gesture of global solidarity towards ...